WebDec 17, 2024 · SHANGHAI, Dec. 17, 2024 /PRNewswire/ -- Shanghai ChemPartner announced the appointment of Jie Jack Li, Ph.D. as a Vice President of Discovery Chem... WebMar 23, 2024 · Mar 23, 2024, 12:02 ET. SHANGHAI, March 23, 2024 /PRNewswire/ -- Shanghai ChemPartner announced today the appointment of Cheng-Chi Chao, Ph.D. as Vice President and Head of Immunotherapy and ...
ChemPartner on LinkedIn: Pharma & Biopharma …
WebSep 17, 2024 · SHANGHAI, Sept. 17, 2024 /PRNewswire/ -- Shanghai ChemPartner announced today the appointment of Steven Yu, Ph.D. as Vice President of Regulated Bioanalysis at the company headquarters in Shanghai ... WebSep 5, 2024 · Therapeutically, we investigated the use of BCMA decoy receptor (sBCMA-Fc) as an inhibitor of APRIL and BAFF. While wild-type sBCMA-Fc effectively blocked APRIL signaling in MM, it lacked activity in DLBCL due to its weak BAFF binding. To expand the therapeutic utility of sBCMA-Fc, we engineered an affinity-enhanced mutant sBCMA … bunge jana dodoma
Developing high-affinity decoy receptors to treat multiple
WebEuropean region’s premier conference for the manufacturing community. Frankfurt, Germany will host this bioprocessing-focused, knowledge-sharing conference to provide regional biopharmaceutical industry stakeholders a carefully tailored networking platform for leveraging opportunities for strategic collaboration, and exposure to the latest … WebJun 10, 2024 · ChemPartner has opened its newest facility, which is located in Qidong, China outside of Shanghai. This 67,000 m 2 campus includes a laboratory center with 5,000 m 2 animal facility ... WebNov 30, 2015 · ChemPartner will be able to expand its clinical research abilities through the investment. The state-of-the-art plant will comply with Western standards in order to support and meet the expectations of international clients. Marketing commentary on ShangPharma, China Gateway Biologics and ChemPartner bunge soja ponta grossa